首页> 外文期刊>Pain medicine : >A multi-center, randomized, double-blind placebo-controlled trial of intravenous-ibuprofen (IV-ibuprofen) for treatment of pain in post-operative orthopedic adult patients.
【24h】

A multi-center, randomized, double-blind placebo-controlled trial of intravenous-ibuprofen (IV-ibuprofen) for treatment of pain in post-operative orthopedic adult patients.

机译:静脉布洛芬(IV-布洛芬)治疗骨科成年术后患者疼痛的多中心,随机,双盲安慰剂对照试验。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE: To determine whether pre- and post-operative administration of intravenous ibuprofen (IV-ibuprofen) can significantly decrease pain and morphine use when compared with placebo in adult orthopedic surgical patients. DESIGN: This was a multi-center, randomized, double-blind placebo-controlled trial. SETTING: This study was completed at eight hospitals; six in the United States and two in South Africa. PATIENTS: A total of 185 adult patients undergoing elective orthopedic surgery. INTERVENTIONS: Patients were randomized to receive either 800 mg IV-ibuprofen or placebo every 6 hours, with the first dose administered pre-operatively. Additionally, all patients had access to intravenous morphine for rescue. OUTCOME MEASURES: Efficacy of IV-ibuprofen was demonstrated by measuring the patient's self assessment of pain using a visual analog scale (VAS; assessed with movement and at rest) and a verbal response scale (VRS). Morphine consumption during the post-operative period was also assessed. RESULTS: In the immediate post-operative period, there was a 25.8% reduction in mean area under the curve-VAS assessed with movement (AUC-VASM) in patients receiving IV-ibuprofen (P < 0.001); a 31.8% reduction in mean AUC-VAS assessed at rest (AUC-VASR; P < 0.001) and a 20.2% reduction in mean VRS (P < 0.001) compared to those receiving placebo. Patients receiving IV-ibuprofen used 30.9% less morphine (P < 0.001) compared to those receiving placebo. Similar treatment emergent adverse events occurred in both study groups and there were no significant differences in the incidence of serious adverse events. CONCLUSION: Pre- and post-operative administration of IV-ibuprofen significantly reduced both pain and morphine use in orthopedic surgery patients in this prospective randomized placebo-controlled trial.
机译:目的:确定与整形外科成年手术患者的安慰剂相比,静脉内布洛芬(IV-布洛芬)的术前和术后给药是否可以显着减少疼痛和吗啡的使用。设计:这是一项多中心,随机,双盲安慰剂对照试验。地点:这项研究是在八家医院完成的。美国有六个,南非有两个。患者:共有185名接受择期骨科手术的成年患者。干预措施:患者每6小时随机接受800 mg IV-布洛芬或安慰剂,并在术前服用第一剂。此外,所有患者均可使用静脉吗啡进行抢救。观察指标:通过使用视觉模拟量表(VAS;通过运动和静止状态评估)和口头反应量表(VRS)来测量患者对疼痛的自我评估,证明了IV-布洛芬的疗效。还评估了术后期间的吗啡消耗量。结果:在接受IV-布洛芬治疗的患者中,在术后即刻,通过运动评估的曲线VAS下面积(AUC-VASM)降低了25.8%(P <0.001);与接受安慰剂的患者相比,静止时评估的平均AUC-VAS降低了31.8%(AUC-VASR; P <0.001),平均VRS降低了20.2%(P <0.001)。与接受安慰剂的患者相比,接受IV-布洛芬的患者使用的吗啡少30.9%(P <0.001)。在两个研究组中都发生了相似的治疗紧急不良事件,严重不良事件的发生率也没有显着差异。结论:在这项前瞻性随机安慰剂对照试验中,术前和术后IV-布洛芬的使用显着减少了骨科手术患者的疼痛和吗啡的使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号